The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Kageyama, S.,
Serruys, P. W.,
Ninomiya, K.,
O'Leary, N.,
Masuda, S.,
Kotoku, N.,
Colombo, A.,
Geuns, R. J. v.,
Milojevic, M.,
Mack, M. J.,
Soo, A.,
Garg, S.,
Onuma, Y.,
Davierwala, P.,
SYNTAX Extended Survival Investigators:
Impact of on-pump and off-pump coronary artery bypass grafting on 10-year mortality versus percutaneous coronary intervention.
Eur. J. Cardio-Thorac. Surg. 64 (2), 1-9, (article identifier: 240), 2023.
Ono, M.,
Hara, H.,
Gao, C.,
Kawashima, H.,
Wang, R.,
O'Leary, N.,
Wykrzykowska, J. J.,
Piek, J. J.,
Mack, M. J.,
Holmes, D. R.,
Morice, M. C.,
Head, S. J.,
Kappetein, A. P.,
Noack, T.,
Davierwala, P.,
Mohr, F. W.,
Garg, S.,
Onuma, Y.,
Serruys, P. W.,
Szerafin, T.:
Mortality after multivessel revascularisation involving the proximal left anterior descending artery.
Heart. 108 (22), 1784-1791, 2022.
Nagy, L.,
Rauch, B.,
Szerafin, T.,
Uray, K.,
Tóth, A.,
Bai, P.:
Nicotinamide-riboside shifts the differentiation of human primary white adipocytes to beige adipocytes impacting substrate preference and uncoupling respiration through SIRT1 activation and mitochondria-derived reactive species production.
Front. Cell. Dev. Biol. 10, 1-12, (article identifier: 979330), 2022.
Laggner, M.,
Hacker, P.,
Oberndorfer, F.,
Bauer, J.,
Raunegger, T.,
Gerges, C.,
Szerafin, T.,
Thanner, J.,
Lang, I.,
Skoro-Sajer, N.,
Ankersmit, H. J.,
Moser, B.:
The Roles of S100A4 and the EGF/EGFR Signaling Axis in Pulmonary Hypertension with Right Ventricular Hypertrophy.
Biology (Basel). 11 (1), 1-19, (article identifier: 118), 2022.
Thuijs, D. J. F. M.,
Kappetein, A. P.,
Serruys, P. W.,
Mohr, F. W.,
Morice, M. C.,
Mack, M. J.,
Holmes, D. R.,
Curzen, N.,
Davierwala, P.,
Noack, T.,
Milojevic, M.,
Dawkins, K. D.,
Costa, B. R. d.,
Jüni, P.,
Head, S. J.,
SYNTAX Extended Survival Investigators:
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.
Lancet. 394 (10206), 1325-1334, 2019.